Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Braun DL, Rauch A, Aouri M, Durisch N, Eberhard N, Anagnostopoulos A, Ledergerber B, Müllhaupt B, Metzner KJ, Decosterd L, Böni J, Weber R, Fehr J; Swiss HIV Cohort Study. Braun DL, et al. Among authors: aouri m. PLoS One. 2015 Jul 15;10(7):e0133028. doi: 10.1371/journal.pone.0133028. eCollection 2015. PLoS One. 2015. PMID: 26176696 Free PMC article. Clinical Trial.
Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake.
Schaerer V, Haubitz S, Kovari H, Ledergerber B, Ambrosioni J, Cavassini M, Stoeckle M, Schmid P, Decosterd L, Aouri M, Böni J, Günthard HF, Furrer H, Metzner KJ, Fehr J, Rauch A; Swiss HIV Cohort Study. Schaerer V, et al. Among authors: aouri m. HIV Med. 2015 Nov;16(10):599-607. doi: 10.1111/hiv.12269. Epub 2015 Jul 2. HIV Med. 2015. PMID: 26135140 Free article.
Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study.
Boillat-Blanco N, Darling KE, Schoni-Affolter F, Vuichard D, Rougemont M, Fulchini R, Bernasconi E, Aouri M, Clerc O, Furrer H, Günthard HF, Cavassini M; Swiss HIV Cohort Study. Boillat-Blanco N, et al. Among authors: aouri m. Antivir Ther. 2015;20(2):165-75. doi: 10.3851/IMP2815. Epub 2014 Jun 25. Antivir Ther. 2015. PMID: 24964403
Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.
Arab-Alameddine M, Lubomirov R, Fayet-Mello A, Aouri M, Rotger M, Buclin T, Widmer N, Gatri M, Ledergerber B, Rentsch K, Cavassini M, Panchaud A, Guidi M, Telenti A, Décosterd LA, Csajka C; Swiss HIV Cohort Study. Arab-Alameddine M, et al. Among authors: aouri m. J Antimicrob Chemother. 2014 Sep;69(9):2489-98. doi: 10.1093/jac/dku131. Epub 2014 May 12. J Antimicrob Chemother. 2014. PMID: 24821595 Free article.
Efavirenz intoxication due to a new CYP2B6 constellation.
Anagnostopoulos A, Rotger M, Aouri M, Kuster SP, Telenti A, Décosterd LA, Günthard HF. Anagnostopoulos A, et al. Among authors: aouri m. Antivir Ther. 2013;18(5):739-43. doi: 10.3851/IMP2571. Epub 2013 May 2. Antivir Ther. 2013. PMID: 23640958
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals.
Arab-Alameddine M, Fayet-Mello A, Lubomirov R, Neely M, di Iulio J, Owen A, Boffito M, Cavassini M, Günthard HF, Rentsch K, Buclin T, Aouri M, Telenti A, Decosterd LA, Rotger M, Csajka C; Swiss HIV Cohort Study Group. Arab-Alameddine M, et al. Among authors: aouri m. Antimicrob Agents Chemother. 2012 Jun;56(6):2959-66. doi: 10.1128/AAC.05424-11. Epub 2012 Feb 27. Antimicrob Agents Chemother. 2012. PMID: 22371894 Free PMC article.
17 results